Phase 4 Melanoma Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Dabrafenib and/or Trametinib Rollover Study
Melanoma
Novartis Pharmaceuticals100 enrolled28 locationsNCT03340506
Recruiting
Phase 4
ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
Metastatic MelanomaAdvanced Melanoma
NYU Langone Health90 enrolled1 locationNCT07504796
Recruiting
Phase 4
RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma
Melanoma Advanced
Fudan University110 enrolled1 locationNCT07445022
Recruiting
Phase 4
Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response
Melanoma
Erasmus Medical Center34 enrolled1 locationNCT06116461